-
Baragana B, Hallyburton I, Lee MC, Norcross NR, et al.
A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 2015;522:315-20.
-
Robinson GW, Orr BA, Wu G, Gururangan S, et al.
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup
Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies
PBTC-025B and PBTC-032. J Clin Oncol 2015.
-
Alcolea D, Martinez-Lage P, Sanchez-Juan P, Olazaran J, et al.
Amyloid precursor protein metabolism and inflammation markers in preclinical
Alzheimer disease. Neurology 2015.
-
Scagliotti G, von Pawel J, Novello S, Ramlau R, et al.
Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of
Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated
Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung % J Clin Oncol 2015.
-
Li L, Streja E, Rhee CM, Mehrotra R, et al.
Hypomagnesemia and Mortality in Incident Hemodialysis Patients. Am J Kidney Dis 2015.
|